Skip to main content

Table 1 Efficacy of various treatment protocols for glioma-bearing animals among different experimental groups

From: Focused ultrasound-induced blood–brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study

Group (n)

Median survival (days)

IST median (%)

Mean survival (days)

IST mean (%)

Maximal survival (days)

p-value

Control (12)

21

21.5

28

FUS (13)

23

9.5

23.9

11.2

32

0.116

IL-12 (12)

26

23.8

25.5

18.6

35

0.004

IL-12 + FUS (13)

30

42.9

31.2

45.1

45

<0.001

  1. Increase in median survival time (ISTmedian; in %), mean survival time (ISTmean; in %) and statistical analysis (Log-rank test and p-value) are all relative to the control group (n = number of animals per group).